Literature DB >> 2064145

Effects of albuterol inhalation on the work of breathing during weaning from mechanical ventilation.

J Mancebo1, P Amaro, H Lorino, F Lemaire, A Harf, L Brochard.   

Abstract

The work of breathing is a major determinant of the success of weaning from mechanical ventilation. The aim of this study was to assess whether an inhaled bronchodilator could reduce the mechanical load on the respiratory muscles and diminish the work. For this purpose, 15 intubated patients in the process of weaning from mechanical ventilation inhaled the beta 2-agonist bronchodilator albuterol via a spacer device filled with 1 mg of the drug and connected to the endotracheal tube. During spontaneous breathing, the mean work of breathing diminished significantly after albuterol, from 9.35 +/- 1.05 to 8.33 +/- 1.13 J/min (p less than 0.01), and seven patients exhibited a decrease superior or equal to 15%. This decrease resulted from a marked reduction in lung and airway resistance, from 12.0 +/- 1.7 to 9.8 +/- 1.4 cm H2O.L-1.s (p less than 0.05). No significant changes were observed in the breathing pattern, intrinsic PEEP or arterial blood gas measurements after albuterol, and peripheral cardiovascular effects were not significant. In seven patients, we were able to compare the changes that occurred after albuterol in the work of breathing during weaning from mechanical ventilation with the changes in pulmonary function induced by albuterol after extubation, as assessed by the forced oscillation method. A close correlation was found between the two types of change, further indicating that the reduction in the work of breathing was more likely to occur in patients with the largest bronchodilating effect of albuterol at baseline.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2064145     DOI: 10.1164/ajrccm/144.1.95

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

Review 1.  Work of breathing.

Authors:  Belen Cabello; Jordi Mancebo
Journal:  Intensive Care Med       Date:  2006-07-13       Impact factor: 17.440

2.  Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury.

Authors:  Michael A Matthay; Roy G Brower; Shannon Carson; Ivor S Douglas; Mark Eisner; Duncan Hite; Steven Holets; Richard H Kallet; Kathleen D Liu; Neil MacIntyre; Marc Moss; David Schoenfeld; Jay Steingrub; B Taylor Thompson
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

Review 3.  Intrinsic positive end-expiratory pressure (PEEPi).

Authors:  A Rossi; G Polese; G Brandi; G Conti
Journal:  Intensive Care Med       Date:  1995-06       Impact factor: 17.440

Review 4.  Adjunctive drug treatment in severe hypoxic respiratory failure.

Authors:  S Elsasser; H Schächinger; W Strobel
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

5.  Aerosol therapy in intensive and intermediate care units: prospective observation of 2808 critically ill patients.

Authors:  Stephan Ehrmann; Ferran Roche-Campo; Laetitia Bodet-Contentin; Keyvan Razazi; Jonathan Dugernier; Josep Trenado-Alvarez; Alexis Donzeau; François Vermeulen; David Thévoz; Metaxia Papanikolaou; Antoine Edelson; Héctor León Yoshido; Lise Piquilloud; Karim Lakhal; Carlos Lopes; Carlos Vicent; Arnaud Desachy; Gabriela Apiou-Sbirlea; Daniel Isabey; Laurent Brochard
Journal:  Intensive Care Med       Date:  2015-11-24       Impact factor: 17.440

6.  Comparison of the effects of pressure support ventilation delivered by three different ventilators during weaning from mechanical ventilation.

Authors:  J Mancebo; P Amaro; J L Mollo; H Lorino; F Lemaire; L Brochard
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

7.  Clinical review: Respiratory monitoring in the ICU - a consensus of 16.

Authors:  Laurent Brochard; Greg S Martin; Lluis Blanch; Paolo Pelosi; F Javier Belda; Amal Jubran; Luciano Gattinoni; Jordi Mancebo; V Marco Ranieri; Jean-Christophe M Richard; Diederik Gommers; Antoine Vieillard-Baron; Antonio Pesenti; Samir Jaber; Ola Stenqvist; Jean-Louis Vincent
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

Review 8.  Bronchodilator delivery with metered-dose inhaler during mechanical ventilation.

Authors:  D Georgopoulos; E Mouloudi; E Kondili; M Klimathianaki
Journal:  Crit Care       Date:  2000-07-11       Impact factor: 9.097

9.  Airway Hygiene in COVID-19 Pneumonia: Treatment Responses of 3 Critically Ill Cruise Ship Employees.

Authors:  Faryal I Farooqi; Richard C Morgan; Naveen Dhawan; John Dinh; George Yatzkan; George Michel
Journal:  Am J Case Rep       Date:  2020-08-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.